Back

Improvement of tricuspid regurgitation in patients treated with transcatheter aortic valve replacement: prognostic impact and factors associated with its regression after the intervention.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Imaging in valvular heart disease Valvular Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Luis Mauricio Milla Mendoza

San Carlos Clinical Hospital, Madrid (Spain)

7 More presentations in this session

Presentation thumbnail
Prognostic impact of normalizing 3D mitral RegVol to LAVmax in HFrEF patients with ventricular secondary MR
Assistant Professor D. Hadareanu (Craiova, RO)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of left atrial and ventricular strain coupling after TAVR: a novel risk assessment approach
Doctor R. Wimolwattanaphan (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Incremental prognostic value of right ventricular free wall longitudinal strain in a staging classification based on cardiac damage in patients with severe aortic stenosis who underwent TAVI
Doctor K. Sato (Tsukuba, JP)
Abstract Slides Video
Presentation thumbnail
Impact of symptoms and left ventricular systolic function in patients with moderate mixed aortic valve disease
Mrs P. Lopez Santi (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Transjugular intracardiac echocardiography-guided transcatheter aortic valve replacement using intra-annular self-expandable valves to reduce permanent pacemaker implantation
Doctor T. Murakami (Kanagawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in valvular heart disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Follow-up and prognosis of tricuspid transcatheter treatment
thumbnail
Congress Presentation
Development of tricuspid regurgitation after left-side heart surgery
thumbnail
Congress Presentation
Rate of progression of tricuspid regurgitation and clinical implications

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources